quinazolines has been researched along with Neointima in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Z; Han, J; Lin, J; Lin, Y; Peng, W; Qin, Y; Shi, X; Xiao, F; Xu, X; Zhang, Y; Zhao, L | 1 |
| Chen, SY; Chuang, YH; Cui, XB; Wang, YC | 1 |
| Hamaguchi, Y; Kawanami, T; Murase, K; Nagaishi, R; Nomiyama, T; Takahashi, H; Tanabe, M; Tanaka, T; Terawaki, Y; Yanase, T | 1 |
3 other study(ies) available for quinazolines and Neointima
| Article | Year |
|---|---|
Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Becaplermin; Cell Plasticity; Cells, Cultured; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Phosphorylation; Plaque, Atherosclerotic; Quinazolines; Signal Transduction | 2021 |
Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
Topics: Animals; Apoptosis; Becaplermin; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Janus Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Quinazolines; Rats; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transfection; Vascular Remodeling | 2017 |
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hypoglycemic Agents; Linagliptin; Male; Mice, Inbred C57BL; Neointima; Purines; Quinazolines; Vascular System Injuries | 2014 |